KEGG   DRUG: Omeprazole and sodium bicarbonate
Entry
D11706            Mixture   Drug                                   
Name
Omeprazole and sodium bicarbonate;
Zegerid (TN)
Product
  Generic
Component
Omeprazole [DR:D00455], Sodium bicarbonate [DR:D01203]
Class
Metabolizing enzyme substrate
 DG01639  CYP2C19 substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Remark
Product: D11706<US>
Efficacy
Anti-ulcerative
  Disease
Duodenal ulcer [DS:H01634]
Gastric ulcer [DS:H01634]
Gastroesophageal reflux disease [DS:H01602]
Comment
Omeprazole is metabolized by CYP2C19 with some contribution from CYP3A4.
Metabolism
Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]
Interaction
Brite
USP drug classification [BR:br08302]
 Gastrointestinal Agents
  Proton Pump Inhibitors
   Omeprazole/ Sodium Bicarbonate
    D11706  Omeprazole and sodium bicarbonate
Drug groups [BR:br08330]
 Metabolizing enzyme substrate
  DG01639  CYP2C19 substrate
   D11706  Omeprazole and sodium bicarbonate
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D11706  Omeprazole and sodium bicarbonate
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D11706
Other DBs
CAS: 774595-73-2
PubChem: 405226572
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system